As DNRF Chair Ana Cvejic will study how the behavior of immune cells changes in solid tumors to support their growth. She plans to leverage the existing platforms and expertise at the BRIC as well as her links to a network of international collaborators who are leading experts in single-cell genomics and spatial transcriptomics. The results from these studies will have a large therapeutic impact through the identification of new therapeutic targets in cancer.